BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.58
-0.02%
US Tech 100
20,375.60
0.55%
S&P 500
6,021.63
0.57%
US Dollar vs CAD
1.40537
-0.21%
Bitcoin
91,950.61
-1.28%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Abivax (ABVX) Share Price

Abivax

Abivax (ABVX)

Abivax SA
7.83
-0.33
(-4.04%)
Closed November 26 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
7.83
Bid
7.55
Ask
8.08
Volume
79,695
7.59 Day's Range 8.09
7.59 52 Week Range 15.42
Market Cap
492.733M
Previous Close
8.16
Open
8.09
Last Trade
24
@
7.83
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
18,622
Shares Outstanding
62,928,818
Dividend Yield
-
PE Ratio
-3.34
Earnings Per Share (EPS)
-2.35
Revenue
4.62M
Net Profit
-147.74M

About Abivax

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abivax.com
Headquarters
Paris, Paris, Fra
Founded
-
Abivax is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ABVX. The last closing price for Abivax was 8.16 €. Over the last year, Abivax shares have traded in a share price range of 7.59 € to 15.42 €.

Abivax currently has 62,928,818 shares outstanding. The market capitalization of Abivax is 513.50 € million. Abivax has a price to earnings ratio (PE ratio) of -3.34.

Ask ADVFN Intelligence (AI)

ABVX Latest News

More News

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

November 19 2024
GlobeNewswire Inc.

Abivax presents third quarter 2024 key financial information

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

November 14 2024
GlobeNewswire Inc.

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax PARIS, France, November 13, 2024, 10:00 pm CET – Abivax SA (Euronext Paris and...

November 13 2024
GlobeNewswire Inc.

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation PARIS, France, October 7, 2024, 10:00...

October 07 2024
GlobeNewswire Inc.

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease PARIS, France, October 3, 2024 – 10:00 p.m. CEST – Abivax SA (Euronext Paris:...

October 03 2024
GlobeNewswire Inc.

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance Patients...

October 03 2024
GlobeNewswire Inc.

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024 Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy...

September 26 2024
GlobeNewswire Inc.

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease...

September 25 2024
GlobeNewswire Inc.

Abivax presents first-half 2024 financial results

Abivax presents first-half 2024 financial results Cash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025 PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA (Euronext...

September 09 2024
GlobeNewswire Inc.

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) surpassed the...

August 06 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.95-10.82004555818.788.857.59225068.3194509DE
4-2.07-20.90909090919.910.127.59170999.03930361DE
12-3.97-33.644067796611.811.987.59186229.29383325DE
26-4.69-37.460063897812.5213.587.591962510.63064255DE
52-1.67-17.57894736849.515.427.592629711.40839267DE
156-17.42-68.990099009925.25295.63161312.29537313DE
260-3.25-29.332129963911.08395.63382316.90967989DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATOAtos SE
0.5628 €
(81.43%)
35.41M
ALNMRNamR SA
0.654 €
(42.17%)
19.06k
EMGDSEuromedis DS
0.0008 €
(33.33%)
5.72k
ALVETEGEIRO Pharma
 0.0918
(28.57%)
222.99k
MLSEQSequa Petroleum NV
0.01 €
(25.00%)
1k
ALNEVNeovacs
0.0001 €
(-50.00%)
56.19M
MLUMGUmalis Group
1.06 €
(-18.46%)
3.09k
ALFLOFlorentaise SA
2.30 €
(-14.18%)
3.49k
GNROGeNeuro SA
0.066 €
(-13.84%)
1,000
ALMDTMedian Technologies
3.06 €
(-12.07%)
116.16k
BCPBanco Comercial Portugues SA
0.445 €
(-0.47%)
61.3M
ALNEVNeovacs
0.0001 €
(-50.00%)
56.19M
ATOAtos SE
0.5628 €
(81.43%)
35.41M
ALCYBCybergun
0.0001 €
(0.00%)
11.7M
ACACredit Agricole SA
12.69 €
(-1.82%)
11.42M

Discussion

View Full Feed
Patrick Bateman Patrick Bateman 2 minutes ago
Uh, this isn't the brag that you may think it is. 
RJDG
Fdc4 Fdc4 2 minutes ago
ORCA MMs did hit you with a baseball on the Kneecap with that 21K shares at $0.008ish 😂 They know ya already… But WTF happened in here? KABOOM to $0.01 AGAIN??? Looking good again!! No complaining, some people got busted for being butter fingers and weak knees in the low
VDRM
Magnum7419 Magnum7419 2 minutes ago
They say those that are impatient will make those that are patient very very rich.......lets see what 2027 will bring me or my heirs :) AHRO
Authentic Holdings Inc (PK)

USOTC


Search
0.0023
0.0002 (9.52%)
Nov 22 2024
- Closed
AHRO
georgie18 georgie18 2 minutes ago
Nice Rig…🥳…thanks for posting…
wadegarret wadegarret 3 minutes ago
Novice- SMCI

How would you go about valuing the stock in light of all the accounting issues they've had ? thanks
SMCI
The Night Stalker The Night Stalker 3 minutes ago
NICE
IGEX
DewDiligence DewDiligence 3 minutes ago
AMGN’s idea to attack obesity using GIP antagonism came from genetic studies in Iceland by Decode Genetics, the (once high-flying) company AMGN acquired in 2012 (#msg-82321447).
AMGN
learningcurve2020 learningcurve2020 4 minutes ago
The number I have is 15,000.  But either way, you're ignoring the meaning of my post, as usual.  
NWBO
golfer101mi golfer101mi 5 minutes ago
0.0000000000002, great job ATIG !! Just love what you have done with the stock!!
ATIG
golfer101mi golfer101mi 5 minutes ago
0.0000000000002, great job ATIG !! Just love what you have done with the stock!!
ATIG
Its_TradingG Its_TradingG 5 minutes ago
You want an answer about details of a fake lawsuit? Not wasting my time with this
ENZC
la-tsla-fan la-tsla-fan 5 minutes ago
Depend on whether you like your meat slow-bled or not...I LOVE IT SLOW-BLED!
TSLA
I-Glow I-Glow 5 minutes ago
Holy Hell, Park busted again. In this press release:

"SPZI: JP3E Commenced Initial Shipment for Sugar Commodity Contract"

In the press release there was a photo of the Sugar they were shipping.

https://investorshub.advfn.com/uimage/uploads/2024/11/26/atad
SPZI
Sideem Sideem 6 minutes ago
Yes! That's a WIN for sure.
BB
kennyt 335 kennyt 335 7 minutes ago
Don’t put it past Nasrat to do just that HGilS, if not tomorrow it is coming!!!!ELTP$$$$$$$$$$$$$$$$$$$$$$
ELTP
bar1080 bar1080 7 minutes ago
Buffett doesn't recommend specific stocks and what he owns by way of BRK is very, very VERY public. Currently BRK has very small, almost trivial positions in two S&P 500 index funds, SPY and Vanguard's VOO. My kids own SPY and my CPA son also has VOO. Both of my kids are now fairly wealthy by most
VOO
bbotcs bbotcs 7 minutes ago
lj: re: oil
There is noise about to the effect that the Trump Administration will reopen Keystone.
That would be good news for Canada's economy. The bad news would be tariffs on everything else!
Pazzo1212 Pazzo1212 7 minutes ago
As soon as the MAA is officially accepted by the EMA, does Missling and team put on a full court press on to find a global partner?  We don't have an experienced sales team with existing market penetration, so we need a team trained and ready to hit every European country full bore.  

AVXL
bubba412 bubba412 8 minutes ago
Stick your chart up your butt I have been watching this for 10 years Goes up around cc time and then does nothing till next one
ELTP
Kaiserwave Kaiserwave 9 minutes ago
Should for sure. I just hope that we don't see anymore added but if 500 million still need to be removed from restricted I'm not really sure how that can work since if you look at the last add to the restricted you can't remove 500 million so curious how that'll work out. Maybe it was done when the
RDAR
IceCold8 IceCold8 9 minutes ago
I wonder what the salaries of the board of directors is with all of this gross underachievement. Sad!
AGSS
Number sleven Number sleven 10 minutes ago
Seve, "anyone who says otherwise is lying" You are one of the special people.
Sleven,
AMRN
waterchaser waterchaser 10 minutes ago
More BS fluff. What happened to the MJ operation? LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/3/20/picfxToilet_.png
GRCU
Whalatane Whalatane 10 minutes ago
ARDX filed for relief of judgement .... to stop Oral pho drugs in dialysis bundle on Jan1 st
CMS responded and asked court for extension into Dec to reply . Extension granted

Nov 25th PDF's
https://drive.google.com/drive/folders/1MVcOMXEQnm3uVwtEX09shUzPE9zow4fW
ARDX

Your Recent History

EU
ABVX
Abivax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68